189 related articles for article (PubMed ID: 34504587)
1. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.
Alexandrescu DM; Mitu O; Costache II; Macovei L; Mitu I; Alexandrescu A; Georgescu CA
Exp Ther Med; 2021 Oct; 22(4):1141. PubMed ID: 34504587
[TBL] [Abstract][Full Text] [Related]
2. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
3. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
4. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.
Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ
J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.
Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773
[TBL] [Abstract][Full Text] [Related]
6. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
7. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
[TBL] [Abstract][Full Text] [Related]
8. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
Kurtul A
Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
[TBL] [Abstract][Full Text] [Related]
10. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
11. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
12. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up.
Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ
Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention.
Wihanda D; Alwi I; Yamin M; Shatri H; Mudjaddid E
Acta Med Indones; 2015 Jul; 47(3):209-15. PubMed ID: 26586386
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions.
Li C; Shen Y; Xu R; Dai Y; Chang S; Lu H; Dong Z; Deng J; Qian J; Ge J
Angiology; 2019 Mar; 70(3):272-278. PubMed ID: 29338303
[TBL] [Abstract][Full Text] [Related]
15. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry.
Gondo K; Ike A; Ogawa M; Shirai K; Sugihara M; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Miura S; Yasunaga S; Saku K
J Cardiol; 2017 Apr; 69(4):652-659. PubMed ID: 27492658
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
Zhang J; Zhang Q; Zhao K; Bian YJ; Liu Y; Xue YT
Medicine (Baltimore); 2022 Nov; 101(47):e31707. PubMed ID: 36451388
[TBL] [Abstract][Full Text] [Related]
17. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
[TBL] [Abstract][Full Text] [Related]
18. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
[TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
Zhao L; Zhu W; Zhang X; He D; Guo C
BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
